IRIS Accounts Production v24.1.0.578 15084193 director 21.8.23 31.3.24 31.3.24 false true false false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh150841932023-08-20150841932024-03-31150841932023-08-212024-03-31150841932023-08-2015084193ns15:EnglandWales2023-08-212024-03-3115084193ns14:PoundSterling2023-08-212024-03-3115084193ns10:Director12023-08-212024-03-3115084193ns10:PrivateLimitedCompanyLtd2023-08-212024-03-3115084193ns10:SmallEntities2023-08-212024-03-3115084193ns10:AuditExempt-NoAccountantsReport2023-08-212024-03-3115084193ns10:SmallCompaniesRegimeForDirectorsReport2023-08-212024-03-3115084193ns10:SmallCompaniesRegimeForAccounts2023-08-212024-03-3115084193ns10:FullAccounts2023-08-212024-03-3115084193ns10:OrdinaryShareClass12023-08-212024-03-3115084193ns10:OrdinaryShareClass112023-08-212024-03-3115084193ns10:RegisteredOffice2023-08-212024-03-3115084193ns5:CurrentFinancialInstruments2024-03-3115084193ns5:ShareCapital2024-03-3115084193ns5:RetainedEarningsAccumulatedLosses2024-03-3115084193ns5:ComputerEquipment2023-08-212024-03-3115084193ns5:ComputerEquipment2024-03-3115084193ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 15084193 (England and Wales)















Unaudited Financial Statements

for the Period 21 August 2023 to 31 March 2024

for

Sns Health Limited

Sns Health Limited (Registered number: 15084193)






Contents of the Financial Statements
for the Period 21 August 2023 to 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Sns Health Limited

Company Information
for the Period 21 August 2023 to 31 March 2024







DIRECTOR: S K T Nanjayan





REGISTERED OFFICE: 32 Ascott Gardens
West Bridgford
Nottingham
NG2 7TH





REGISTERED NUMBER: 15084193 (England and Wales)





ACCOUNTANTS: G Ceidiog Hughes Limited
40 Brookhouse Road
Denbigh
Clwyd
LL16 4RQ

Sns Health Limited (Registered number: 15084193)

Balance Sheet
31 March 2024

Notes £    £   
FIXED ASSETS
Tangible assets 4 999

CURRENT ASSETS
Debtors 5 119
Cash at bank 225
344
CREDITORS
Amounts falling due within one year 6 1,749
NET CURRENT LIABILITIES (1,405 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(406

)

CAPITAL AND RESERVES
Called up share capital 7 100
Retained earnings (506 )
SHAREHOLDERS' FUNDS (406 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Sns Health Limited (Registered number: 15084193)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 31 October 2024 and were signed by:





S K T Nanjayan - Director


Sns Health Limited (Registered number: 15084193)

Notes to the Financial Statements
for the Period 21 August 2023 to 31 March 2024

1. STATUTORY INFORMATION

Sns Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the Company's accounting policies, management is required to make judgements, estimates and assumptions about carrying values of assets and liabilities that are not readily available from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered relevant. Actual results may differ from these estimates.

The key judgements and sources of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described below:

Estimated useful lives and residual values of fixed assets
Depreciation of tangible fixed assets has been based on estimated useful lives and residual values deemed appropriate by the directors. Estimated useful lives and residual values are reviewed annually and revised as appropriate. Revisions take into account estimated useful lives used by other companies operating in the sector and actual asset lives and residual values, as evidenced by disposals during current and prior accounting periods.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 20% on cost

Financial instruments
The following assets and liabilities are classified as financial instruments - trade debtors and trade creditors.

Trade debtors and trade creditors are measured at the undiscounted amount of cash or other consideration expected to be paid or received.

Financial assets are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit and loss.

Sns Health Limited (Registered number: 15084193)

Notes to the Financial Statements - continued
for the Period 21 August 2023 to 31 March 2024

2. ACCOUNTING POLICIES - continued

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
Additions 999
At 31 March 2024 999
NET BOOK VALUE
At 31 March 2024 999

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Deferred tax asset 119

Sns Health Limited (Registered number: 15084193)

Notes to the Financial Statements - continued
for the Period 21 August 2023 to 31 March 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Directors' current accounts 1,250
Accrued expenses 499
1,749

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
100 Ordinary £1 100

100 Ordinary shares of £1 were issued during the period for cash of £ 100 .

8. CAPITAL COMMITMENTS
£   
Contracted but not provided for in the
financial statements -

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is S K T Nanjayan.

10. COMPARATIVE FIGURES

There are no comparative figures as this is the first period of trading.